Fourth quarter EBITDA was $99 million versus a loss of $7 million a year earlier.
Breaking
Swedish scientists have developed a fat-burning pill that controls blood sugar with fewer side effects than Ozempic, offering hope for diabetes treatment....
https://thefederalist.com/2025/12/10/the-supreme-court-should-overturn-wong-kim-ark/?utm_source=rss&utm_medium=rss&utm_campaign=the-supreme-court-should-overturn-wong-kim-ark...
https://www.newsnationnow.com/us-news/military/us-force-venezuela-trump-targets-expanded/...
loading...